Patients with bone and soft tissue sarcomas are treated in the Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center by a multidisciplinary team of cancer experts. Orthopedic ...
The SU2C-SARC032 study demonstrated that pembrolizumab combined with radiotherapy and surgery was well tolerated, with ...
The FDA has given accelerated approval to a groundbreaking T cell-based therapy from Adaptimmune for synovial sarcoma, becoming the first new treatment for the rare soft tissue cancer in more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback